Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barlocco

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Il Farmaco; Edizione Scientifica|August 1, 1987
Antihypertensive and antithrombotic activities of 6-(substituted phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)pyridazinonesD Barlocco, A Martini, G A Pinna, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 19, 1999
Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivativesD Barlocco, G Cignarella, P Vianello, et al.
Journal of Medicinal Chemistry|November 1, 1986
Conformationally restricted congeners of hypotensive and platelet aggregation inhibitors: 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones derived from 5H-indeno[1,2-c]pyridazineG Cignarella, D Barlocco, G A Pinna, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Conformational analysis of phthalein derivatives acting as thymidylate synthase inhibitors by means of 1H NMR and quantum chemical calculationsS Ghelli, G Rastelli, D Barlocco, et al.
Pharmacological Research|May 1, 1997
Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in ratsE Barocelli, M Chiavarini, V Ballabeni, et al.
Il Farmaco; Edizione Scientifica|February 1, 1988
New congeners of antihypertensive and antithrombotic 7-amino or 7-acetyl-aminosubstituted-4,4a-dihydro-5H-indeno (1,2-c)pyridazin-3-onesG Cignarella, D Barlocco, L Landriani, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 1, 1992
Synthesis and pharmacological activity of 4-carbamoyl-5-aryl-6-methyl-4,5-dihydropyridazin-3(2H)-onesG A Pinna, F Sardu, M M Curzu, et al.
Il Farmaco; Edizione Scientifica|June 1, 1988
Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)onesG A Pinna, M M Curzu, D Barlocco, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1989
Diuretic agents related to indapamide. III--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-1,2,3,4-tetrahydroquinolines and 1,2,3,4-tetrahydroisoquinolinesL Landriani, D Barlocco, G A Pinna, et al.
Bioorganic & Medicinal Chemistry|September 8, 1998
Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studiesF Montesano, D Barlocco, V Dal Piaz, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Il Farmaco; Edizione Scientifica|August 1, 1987
Antihypertensive and antithrombotic activities of 6-(substituted phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)pyridazinonesD Barlocco, A Martini, G A Pinna, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 19, 1999
Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivativesD Barlocco, G Cignarella, P Vianello, et al.
Journal of Medicinal Chemistry|November 1, 1986
Conformationally restricted congeners of hypotensive and platelet aggregation inhibitors: 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones derived from 5H-indeno[1,2-c]pyridazineG Cignarella, D Barlocco, G A Pinna, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Conformational analysis of phthalein derivatives acting as thymidylate synthase inhibitors by means of 1H NMR and quantum chemical calculationsS Ghelli, G Rastelli, D Barlocco, et al.
Pharmacological Research|May 1, 1997
Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in ratsE Barocelli, M Chiavarini, V Ballabeni, et al.
Il Farmaco; Edizione Scientifica|February 1, 1988
New congeners of antihypertensive and antithrombotic 7-amino or 7-acetyl-aminosubstituted-4,4a-dihydro-5H-indeno (1,2-c)pyridazin-3-onesG Cignarella, D Barlocco, L Landriani, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 1, 1992
Synthesis and pharmacological activity of 4-carbamoyl-5-aryl-6-methyl-4,5-dihydropyridazin-3(2H)-onesG A Pinna, F Sardu, M M Curzu, et al.
Il Farmaco; Edizione Scientifica|June 1, 1988
Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)onesG A Pinna, M M Curzu, D Barlocco, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1989
Diuretic agents related to indapamide. III--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-1,2,3,4-tetrahydroquinolines and 1,2,3,4-tetrahydroisoquinolinesL Landriani, D Barlocco, G A Pinna, et al.
Bioorganic & Medicinal Chemistry|September 8, 1998
Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studiesF Montesano, D Barlocco, V Dal Piaz, et al.
Pageof 7